Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Healthcare Biotechnology
Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

9342-8530 Quebec Inc
Bullboard Posts
User Avatar Image
(33)
•••
Comment by SurfForWealthon Nov 28, 2003 6:37am
218 Views
Post# 6710691

RE: Nice move, much more to come

RE: Nice move, much more to comeThe technicals look great, both daily & weekly, the volume is strong & the stock continues to gap up with minimal retracement. The stock could have tremendous upside as more investors discover the stock & understand the story. Here is a small $66M company with no debt, cash on the balance sheet, 2 new products that are generating revenue now, profitable from this point forward & a signed deal that could generate over $120M USD per year in royalties which would have huge net margins making the company extremely profitable. There does not seem to be any reason for dilution. This stock has nearly all the qualities I look for in a small cap investment. Good luck, Cheers!!!
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities